Skip to Main content Skip to Navigation
Journal articles

The refusal of the Society to accept antibiotic toxicity: missing opportunities for therapy of severe infections

Abstract : Over the last decade the emergence and spread of antibiotic resistance in bacteria has led to a new fear in the scientific and medical communities as well as among members of the general public. Due to the lack of development of new antibiotics, there is a need to reconsider old drugs or dosages rejected because of their toxicity. As a society, if we tolerate the potential toxicity of other drugs, such as anticancer drugs, why do we refuse to accept the use of toxic but effective antibiotics in life-threatening infections? The aim of this review is to provide insight into the reasons why the medical community remains unjustifiably unwilling to accept the risk of toxicity and the adverse effects of antibiotics that, nonetheless, might be required to treat severe infections, including those due to multidrug-resistant bacteria. (C) 2016 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Document type :
Journal articles
Complete list of metadata

https://hal.archives-ouvertes.fr/hal-01458380
Contributor : Isabelle Combe Connect in order to contact the contributor
Submitted on : Monday, February 6, 2017 - 6:59:38 PM
Last modification on : Wednesday, November 3, 2021 - 9:37:26 AM

Links full text

Identifiers

Collections

Citation

Jean-Marc Rolain, F. Baquero. The refusal of the Society to accept antibiotic toxicity: missing opportunities for therapy of severe infections. Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2016, 22 (5), pp.423-427. ⟨10.1016/j.cmi.2016.03.026⟩. ⟨hal-01458380⟩

Share

Metrics

Les métriques sont temporairement indisponibles